What are the Major Growth Opportunities in Oncology Diagnostics in In Vitro Diagnostics?
Amidst fierce competition and rapid technological advancement, how does your team ensure its stance? Do you have personalized strategies for improved cancer therapy? Discover game-changing developments in healthcare and leverage them for success.
Small Molecule Contract Development and Manufacturing Organizations: What are the New Growth Opportunities?
Who are the top participants? What are their revenue share estimates? Get an overview of the key developments such as capacity expansions, mergers, acquisitions, and expanding service offerings that are set to affect the overall sector growth.
What are the Transformative Growth Opportunities and Innovations for the Global Telehealth Sector?
Does remote patient monitoring drive chronic disease control? How to accelerate user awareness to trigger novel growth opportunities? Assess value-based care and health equity's relevance in the present and how they can drive significant growth in this domain.
Soft Tissue Navigation Systems
Is your team capitalizing on the next-generation surgical robotics technologies?
Stroke Care Continuum Space
What are the growth drivers? Is telestroke care the next groundbreaking advancement?
Technology-enabled Drug Discovery
Explore novel business models fostering the rise of technology-driven therapeutic providers
Advance Sequencing Informatics
Explore how technology-supported genomics and precision medicine fuel massive growth
Healthcare Data Analytics
How can your team gain a competitive edge amidst strong entrants in the United States?
Tissue-engineered Skin Substitute
What are the new types? Which emerging manufacturing technologies are driving growth?
Continuous Glucose Monitoring
What are the key opportunities in type 2 diabetic and non-diabetic patients’ treatment?
Hospitals of Tomorrow: Digital Advances
Which technologies ensure a provider-activated patient care network while fueling growth?
Right-shoring and Innovation in Oral Dosage Forms Emerge as Top Growth Opportunities for Small Molecule Contract Development & Manufacturing Organizations (CDMO)
Managing optimal inventory levels remains vital as CDMOs work on multiple projects simultaneously. This can lead to inventory management issues, including understocking or overstocking of materials, expiration of materials, and increased costs due to inventory holding. With speed and timely delivery of products emerging as primary criteria for partner selection, strategies around minimizing the supply chain issues emerged as vital drivers to growth. Therefore, a multi-sourcing strategy and right-shoring to address cost and efficiency concerns are transforming CDMOs.
Mission Possible: Serving The Vulnerable Tier-2 & 3 Kidney Care Patients
Explore the global campaigns geared toward raising awareness to reduce the frequency and impact of kidney disease and its associated health problems. Find out the major government efforts to expand the overall dialysis network and provide free dialysis services to the poor. Discover how the private sector is fueling the momentum of change.
Top 5 Developments to Watch in the Middle East Healthcare & Life Sciences Industry
MedTech sector domestic manufacturing will gradually take over in the Gulf Cooperation Council (GCC) region. GCC countries will witness hospital investments in digital health infrastructure. Focus on localization (vision 2030 in KSA & MoHAP UAE) alongside expedited drug approval in the GCC region will attract greater investments from Pharma MNCs. Artificial intelligence (AI) in the radiology value chain will be driven by hospital investments in GCC. As IVD moves towards decentralized testing, there will be an increasing demand for respiratory pathogen panel testing in the GCC region.
Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Leading Position
Frost & Sullivan assessed the landscape for real-world evidence (RWE) information technology (IT) solutions for the healthcare industry and, based on its analysis, recognizes Optum with the 2023 North American Company of the Year Award. The RWE division operates in the healthcare life sciences industry, with access to 285 million lives worth of deidentified real-world data (RWD).
Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data
Frost & Sullivan analyzed the Asia-Pacific biotechnology contract research organization (CRO) industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award. The company is a leading CRO with over 20 years of experience and provides comprehensive clinical research services to drug sponsors worldwide.
Subang Jaya Medical Centre Awarded Frost & Sullivan’s Company of the Year Award
Frost & Sullivan assessed the Malaysian healthcare industry and, based on its findings, recognizes Subang Jaya Medical Centre (SJMC) with the 2023 Company of the Year Award for the third consecutive year, affirming its solid commitment to patient care. SJMC continually adopts clinical and operational management solutions and purposefully uses digital technology to increase efficiencies across the entire workflow, making it the leading hospital in the Malaysian private healthcare industry.
Precision Health
Growth Opportunities in Global Precision Health - Beyond Probiotics: Exploring the Microbiome & Medicinal Foods in Precision Health
Sep 7th, 2023 09:00 AM EDT
Women's Health
Growth Opportunities in Global Women’s Health - EmpowerHer: Food and Drug Administration's Bold Vision for Women
Sep 13th, 2023 09:00 AM EDT
Chronic Care
Growth Opportunity in Global Chronic Care - Diabetes Prevention & Management in 2030: Innovations & Opportunities
Sep 14th, 2023 11:00 AM EDT
Healthcare IT
Growth Opportunities in Global Healthcare IT: From Chatbots to Voice Recognition: Is Conversational AI Crucial for Healthcare?
Sep 21st, 2023 11:00 AM EDT
.png)